Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (189)	1/12/2003 11:57:58 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

MEDC Was up 26.49% on Friday on volume of 975,676 (more than 11x its daily average) after it announced that it had reached an agreement with BDX on their dispute concerning the BD Integra syringe. BDX agreed to pay MEDC a 2.5 percent royalty, not only on all sales in the U.S., but also on all international markets where MEDC's retracting needle syringe patents are in force. The stock was able to close above its December and November Hs. siliconinvestor.com And it may get to test its June-July resistance around the 13 level. siliconinvestor.com Bernard